RBI
EBS icon

Raiffeisen Bank International’s Emergent Biosolutions EBS Stock Holding History

Raiffeisen Bank International’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-400
Closed -$3.11K – 843
2025
Q2 		$2.55K Hold
400
– – ﹤0.01% 569
2025
Q1 		$1.94K Hold
400
– – ﹤0.01% 586
2024
Q4 		$3.27K Buy
+400
New +$3.67K ﹤0.01% 582

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1.16B AUM 53.61% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
VFA
Values First Advisors Gray, Tennessee $219M AUM 33.32% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Raiffeisen Bank International's EBS Position: Q3 2025 in Review

Raiffeisen Bank International sold out of Emergent Biosolutions (EBS) in Q3 2025, closing a stake of 400 shares — an estimated $3.11K sold.

Raiffeisen Bank International first reported a position in EBS in Q4 2024 and held it in 3 quarters. The position peaked at $3.27K in Q4 2024. 169 funds tracked by Wall St. Rank hold EBS as of Q3 2025.

  • Raiffeisen Bank International reported no remaining Emergent Biosolutions position as of Q3 2025 after selling out during the quarter.
  • Raiffeisen Bank International sold 400 Emergent Biosolutions shares in Q3 2025, an estimated $3.11K.
  • Raiffeisen Bank International first reported a position in Emergent Biosolutions in Q4 2024 and held it in 3 quarters.
  • Raiffeisen Bank International's Emergent Biosolutions position peaked at $3.27K in Q4 2024.
  • 169 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2025.

Based on Raiffeisen Bank International's 13F filing for Q3 2025, filed 10 Nov 2025.